Medical experts are sounding the alarm on a potential triple-demic as cases of COVID-19, respiratory syncytial virus (RSV), and the flu are on the rise this winter. In particular, a new strain of COVID-19, known as JN1, has become the dominant variant in the United States, accounting for more than 44% of new cases, according to the Centers for Disease Control and Prevention (CDC).
Despite the increasing prevalence of JN1, medical authorities emphasize that it is not more severe than other COVID-19 strains. However, they caution that its rapid spread, coupled with the ongoing holiday travels, may lead to a surge in cases. Currently, the South and Midwest regions are experiencing higher concentrations of the JN1 variant. To mitigate the risk, individuals in high-risk groups are advised to have rapid tests on hand and engage in conversations with their physicians regarding antiviral treatments and vaccination options.
